2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
about
Ischemic heart disease in women: a focus on risk factorsRisk scoring for the primary prevention of cardiovascular diseaseReduction in saturated fat intake for cardiovascular diseasePreoperative statin therapy for patients undergoing cardiac surgeryFixed-dose combination therapy for the prevention of cardiovascular diseaseStatin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherencePreoperative statin therapy for patients undergoing cardiac surgeryCardiovascular risk assessment in rheumatoid arthritis - controversies and the new approachStabilization of high-risk plaquesHuman Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining Conditions2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation)PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumabDiabetes DyslipidemiaManagement of intracerebral hemorrhage--use of statinsDyslipidemia management in primary prevention of cardiovascular disease: Current guidelines and strategiesImproved Cardiovascular Disease Outcomes in Older AdultsRisk of new-onset diabetes associated with statin usePrevention, Detection and Management of Coronary Artery Disease in Minority FemalesReducing Medication Costs to Prevent Cardiovascular Disease: A Community Guide Systematic ReviewInternal Iliac Artery Stenosis: Diagnosis and How to Manage it in 2015Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trialsQuality markers in cardiology: measures of outcomes and clinical practice--a perspective of the Spanish Society of Cardiology and of Thoracic and Cardiovascular SurgeryInterventions to improve adherence to cardiovascular disease guidelines: a systematic reviewDiabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future researchNew developments in atherosclerosis: clinical potential of PCSK9 inhibitionOrigin and therapy for hypertriglyceridaemia in type 2 diabetesNon-alcoholic fatty liver disease: what has changed in the treatment since the beginning?Gastric cancer: descriptive epidemiology, risk factors, screening, and preventionStatins: definitive translational researchStatins, cognition, and dementia—systematic review and methodological commentaryEvolution of lipid management guidelines: evidence might set you freeCoronary atherosclerosis is already ongoing in pre-diabetic status: Insight from intravascular imaging modalitiesPrimary prevention with statins in cardiovascular diseases: A Saudi Arabian perspectivePhenotype standardization for statin-induced myotoxicityCoronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) StudyThe role of statins in the setting of HIV infectionUpdate on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Diagnosis and treatment of high density lipoprotein deficiencyOverview of guidelines for the management of dyslipidemia: EU perspectivesCardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
P2860
Q22251459-FC0D0844-E1B5-4BF9-A94C-DBF7A0FB8439Q24186884-2048FAF0-33E4-4877-B743-2BF04B0B22AFQ24187203-DD10412A-F358-485A-A44C-8D28508820D5Q24187896-4187FC91-C211-44D5-9D01-E8F4FDA11266Q24195065-BE67EBB5-8B60-445F-B7AA-AC294D502AFFQ24658518-EB36F74F-9B17-464A-A61C-19BF0AE62941Q26472003-19BB08F2-6D6B-430E-B201-9CE0549D5A1EQ26738461-80DDBA96-77E8-4563-AFEA-0D8036F7F3BFQ26738584-A7A7E806-3AB4-44CC-B518-AB78CBA110CFQ26740117-F8367E37-B79C-4730-9B80-33CF4AF9E39DQ26747559-39C44473-6969-41E8-88A3-376D700D70B8Q26747776-925DCA7F-3BD2-48B2-85E1-8FB08C6BB267Q26750905-FC9CEFF7-ED34-42C9-8B84-D85F2F83238EQ26752952-7EF599C7-418A-499C-8463-28377148C66EQ26765157-A92F2BD3-F3B1-4519-AEC6-9D1287F99BFFQ26766094-F0C59F45-581F-432C-8F93-8E2FACA38081Q26771800-13409AEB-50AF-469A-B5D0-89F370CA3474Q26775494-9132883B-1372-4590-B65B-631F88C3514DQ26775544-6EA59FAF-8972-41FE-B7D6-A0714880B38EQ26776106-16E6AC11-879D-4152-9BDD-B09E685CFFFEQ26776293-7D886CF4-D199-4379-9C16-D2F30004C2E1Q26778567-DF13B63A-D132-426D-99AD-4FC4CF344D2BQ26780327-E1722407-5E79-4727-99A2-E474776A7A72Q26782844-BA8B3A0E-0551-49F3-B3EB-993B8EB098DDQ26783407-FC6C79BF-2B61-4704-8BE4-67DEE7D3D96FQ26824004-88809DA6-9F67-479F-B860-29B450423049Q26829503-7DCE1E11-66B0-4923-885B-AD5484A0FB1AQ26849435-6CB0B219-E71A-4EFC-83C7-6C9E1B966D76Q26851528-59694FF3-30EA-4D72-B842-D4448E70A4DDQ26852778-A69CFA76-C321-4EC9-BF92-64045F6CAB29Q26861250-7307BC84-58D5-424D-A95E-42B2D58ED1F0Q26866204-58F70DB2-47E4-48EC-BC5C-A3700C40CE21Q27002928-295307A8-D735-4BA7-B1E8-29249E14CE42Q27020935-85FD8FB8-E0D2-4F1B-ABFC-09A9CBDEE3BDQ27026525-3A7768F7-4F6B-4DAA-9CE4-C616B0B8D6CAQ27027724-E00C84C0-8C30-4553-8BD4-E2F578D7CD9BQ27687851-986DED52-55BC-40C7-B5F5-01680E6F88AEQ28067479-3F1F4A6B-A528-41AF-B2CE-DC6FB685F833Q28069411-1475159A-042C-4D1F-9F58-585B789F55FDQ28071764-2FB1832C-C16D-44AF-9C2C-24212F632C31
P2860
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
2013 ACC/AHA guideline on the ...... k Force on Practice Guidelines
@ast
2013 ACC/AHA guideline on the ...... k Force on Practice Guidelines
@en
2013 ACC/AHA guideline on the ...... k Force on Practice Guidelines
@nl
type
label
2013 ACC/AHA guideline on the ...... k Force on Practice Guidelines
@ast
2013 ACC/AHA guideline on the ...... k Force on Practice Guidelines
@en
2013 ACC/AHA guideline on the ...... k Force on Practice Guidelines
@nl
prefLabel
2013 ACC/AHA guideline on the ...... k Force on Practice Guidelines
@ast
2013 ACC/AHA guideline on the ...... k Force on Practice Guidelines
@en
2013 ACC/AHA guideline on the ...... k Force on Practice Guidelines
@nl
P2093
P50
P3181
P1433
P1476
2013 ACC/AHA guideline on the ...... k Force on Practice Guidelines
@en
P2093
Alice H Lichtenstein
Anne C Goldberg
Biykem Bozkurt
C Noel Bairey Merz
Conrad B Blum
Daniel Levy
David DeMets
David Gordon
Frank W Sellke
Gordon F Tomaselli
P3181
P356
10.1161/01.CIR.0000437738.63853.7A
P407
P433
25 Suppl 2
P577
2014-06-24T00:00:00Z